Cytosorbents Corp expected to post a loss of 16 cents a share - Earnings Preview

Cytosorbents

02/11/2022 02:10

* Cytosorbents Corp  CTSO.OQ   CTSO.O  is expected to show a
fall
in quarterly revenue when it reports  results on November 3. 
    * The Princeton New Jersey-based  company is expected to
report  a
8.0% decrease in revenue to $8.979 million from $9.76 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytosorbents Corp
is for
a loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Cytosorbents Corp
is $8.5​, above​ its last closing price of $1.89. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.14       -0.13      -0.25     Missed  -86.9
 Mar. 31 2022  -0.12       -0.12      -0.21     Missed  -71.4
 Dec. 31 2021  -0.17       -0.13      -0.21     Missed  -58.6​
 Sep. 30 2021  -0.15       -0.12      -0.15     Missed  -23.3
 ​​Jun.        -0.04       -0.04      -0.11     Missed  -181
 30 2021                                                
 Mar. 31 2021  -0.02       -0.03      -0.10     Missed  -200​
 Dec. 31 2020  -0.04       -0.04      0.00      Beat    100
 Sep. 30 2020  -0.09       -0.09      -0.02     Beat    77.9
 This summary was machine generated November 2 at 02:10 GMT.  All
figures in US dollars  unless otherwise stated